Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
48.03 USD | -1.94% | -18.95% | -42.21% |
May. 23 | Raymond James Adjusts Price Target on Cytokinetics to $70 From $92, Maintains Outperform Rating | MT |
May. 23 | Sector Update: Health Care Stocks Flat to Lower Premarket Thursday | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-42.20% | 5.62B | |
+12.03% | 116B | |
+12.94% | 106B | |
-9.90% | 23.89B | |
-1.69% | 21.58B | |
-10.60% | 18.96B | |
-41.25% | 16.96B | |
-14.54% | 16.33B | |
+6.66% | 14.14B | |
+31.11% | 12.02B |
- Stock Market
- Equities
- CYTK Stock
- News Cytokinetics, Incorporated
- Cytokinetics Q4 Net Loss Narrows, Revenue Decreases; 2024 Outlook Issued